Increase the predictability of global financing and improve the sustainability of national financing for immunisation
Given the significant pressures on national budgets in the wake of the 2009 financial crisis, ensuring that both donors and developing countries remain committed to investing in vaccines is critical to the continued success of the GAVI mission.
Strategic goal three recognises that widening GAVI's donor base to secure long-term, predictable funding is critical to meeting increased demand for new vaccines against pneumococcal and rotavirus infections.
Likewise, raising the extent to which developing countries contribute to the cost of vaccines themselves will reduce the short-term pressure on the Alliance's available funds.
- Resource mobilisation: resources mobilised as a % of resources needed to finance forecasted country demand for vaccine support.
- Country investments in vaccines per child: average government expenditure on vaccines per surviving infant.
- Fulfilment of co-financing commitments: % of countries that meet their co-financing commitments in a timely manner.
- View GAVI's targets for its financing goal
Over the next five years, securing additional resources will be critical to fund GAVI's plans to rollout vaccines like rotavirus and pneumococcal to developing countries.
With this in mind, strategic goal three supports a strategic shift toward a new resource mobilisation model, requiring a more integrated approach to advocacy, communication, public policy, innovative financing and donor relations.
The new model envisages:
Financial sustainability has been a core principle of GAVI's mission since its inception, with developing countries encouraged to co-finance or contribute to the cost of purchasing their vaccines with the Alliance. In 2010, 53 countries co-financed GAVI-supported vaccines compared with 27 in 2008.
For the period 2011-15, strategic goal three aims to secure commitments from low and middle income countries to co-finance, as well as assist some countries ready to 'graduate' to covering the full cost of their national vaccination programmes.
To do this, GAVI will focus on institutionalising vaccine spending in national budgets and health planning.